| related words |
| nx |
| biovaxid |
| devoted |
| clinically |
| endpoint |
| ibis |
| survival |
| zyflo |
| kit |
| genentech |
| estrasorb |
| sg |
| prenatal |
| revimmune |
| metastatic |
| molecule |
| verified |
| sublicensees |
| deploying |
| observe |
|
| related documents |
| 8855--9/4/2007--AMERICAN_LOCKER_GROUP_INC |
| 1412067--5/6/2010--Oncothyreon_Inc. |
| 1348259--2/27/2009--VALIDUS_HOLDINGS_LTD |
| 898660--3/31/2009--STATION_CASINOS_INC |
| 1412067--3/30/2009--Oncothyreon_Inc. |
| 1176316--3/31/2006--ACCESS_NATIONAL_CORP |
| 1344413--3/10/2009--Alexza_Pharmaceuticals_Inc. |
| 1080014--2/27/2009--THERAVANCE_INC |
| 2135--8/28/2008--AFFILIATED_COMPUTER_SERVICES_INC |
| 1130591--2/22/2008--XENOPORT_INC |
| 1080014--2/26/2010--THERAVANCE_INC |
| 1080014--2/27/2008--THERAVANCE_INC |
| 1412067--3/17/2008--Oncothyreon_Inc. |
| 1130591--3/7/2007--XENOPORT_INC |
| 1232229--9/13/2007--SYNTAX-BRILLIAN_CORP |
| 1028205--9/12/2007--BIOENVISION_INC |
| 1129425--3/14/2006--ZYMOGENETICS_INC |
| 2135--8/29/2007--AFFILIATED_COMPUTER_SERVICES_INC |
| 1344413--3/17/2008--Alexza_Pharmaceuticals_Inc. |
| 2135--8/27/2009--AFFILIATED_COMPUTER_SERVICES_INC |
|
| related topics |
| {product, candidate, development} |
| {cost, contract, operation} |
| {interest, director, officer} |
| {gas, price, oil} |
| {control, financial, internal} |
| {cost, regulation, environmental} |
| {tax, income, asset} |
| {stock, price, share} |
| {competitive, industry, competition} |
| {operation, international, foreign} |
| {personnel, key, retain} |
| {stock, price, operating} |
| {investment, property, distribution} |
| {capital, credit, financial} |
| {product, liability, claim} |
| {product, market, service} |
| {acquisition, growth, future} |
| {property, intellectual, protect} |
| {system, service, information} |
| {cost, operation, labor} |
|